Sat, Oct 25, 2014, 3:19 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • themicrokid themicrokid Nov 29, 2012 10:11 AM Flag

    The right SRPT deal might make VRTX management look like geniuses!

    My model is $440 million revenue on 1463 US patients. Next 4 exons will bring many patients, US, Europe, Japan. Think 11,000 at 60% penetration. If GSK/Prosensa continue to have toxicity issues they will come under pressure and allow Eteplirsen in EU and Japan for a royalty.

    Many more possibilities in the exon skipping world to come.

    Sentiment: Buy

109.91+1.82(+1.68%)Oct 24 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.